PRODUCT

°í°´¸¸Á·À» À§ÇØ Áö¼ÓÀûÀ¸·Î °í¹ÎÇϰí Çõ½ÅÇÏ¿© ÃÖ°íÀÇ Ç°ÁúÀ» Á¦°øÇÕ´Ï´Ù.

R&D reagents

Product > R&D reagents
Cisatracurium besylate, 98% (HPLC)
CAS No N769-10mg
Á¦Ç°¹øÈ£ AK Sci.(USA)
Á¦Á¶»ç ¼öÀÔ»ê
Àç°í 1 EA
±Ý¾× 106,000¿ø
Æ÷Àå´ÜÀ§
Æ÷Àå´ÜÀ§




¡Ø È­Çиí : Cisatracurium besylate, 98% (HPLC)

 

¡Ø µî±Þ : APIs and Bioactives > AChR Agonists

 

¡Ø ÆÇ¸Å Æ÷Àå´ÜÀ§ : 10mg , 25mg , 100mg

 

¡Ø È­ÇÐ½Ä : C53H72N2O12.2(C6H5O3S)

 

¡Ø CAS # : [96946-42-8]


 

IDENTITY
CAS Registry #: [96946-42-8]
MDL Number: MFCD00871018
MF: C53H72N2O12.2(C6H5O3S)
MW: 1243.4781
SPECIFICATIONS & PROPERTIES
Purity: 98% (HPLC)
Available Spectra: NMR, FT-IR, MS, HPLC
Physical Form: Off-white to light yellow powder
Melting Point: 93-102¡ÆC
Long-Term Storage:

 

Store long-term at 2-8¡ÆC

Shipping: Regulated for Shipping
UN #: 2811
Hazard Class: 6.1
Packing Group: III

BIOLOGICAL INFO
Application(s): Nondepolarizing skeletal muscle relaxant

REVIEW

Cisatracurium Besylate binds to the nicotinic acetycholine (cholinergic) receptors in the motor endplate and blocks access to the receptors. In the process of binding, the receptor is actually activated - causing a process known as depolarization. Since it is not degraded in the neuromuscular junction, the depolarized membrane remains depolarized and unresponsive to any other impulse, causing muscle paralysis.

Risk Description(s)
R36/37/38: Irritating to eyes, respiratory system and skin

Safety Description(s)
S24/25: Avoid contact with skin and eyes.